Dmitry Kaminskiy is an innovative entrepreneur and investor active in the fields of Longevity, Precision Medicine, and Artificial Intelligence. He is co-founder and managing partner at Deep Knowledge Ventures, a leading investment fund focused on DeepTech, renowned for its use of sophisticated analytical systems for investment target identification and due-diligence. 

     He is a frequent speaker on AI and Longevity, including events organized in London by The Economist “Aging Societies and The Business of Longevity”, Financial Times “Smart Machines vs Smart People”, Financial Times “Global Pharmaceutical and Biotechnology Conference”, the "Precision Medicine World Conference" in Silicon Valley as well as others at Oxford and Cambridge Universities.

     He is actively involved in the work of the initiative group and was instrumental at the initial stage of the launch of the All-Party Parliamentary Group for Longevity in the UK Parliament. He now serves as co-director of the secretariat, overseeing the APPG’s international Longevity cooperation development division. He is also supervising all of the APPG’s activities related to the development of Centres of Artificial intelligence for Preventive Medicine in the UK.

​

     Deep Knowledge Ventures Investment Fund and its analytical subsidiary Deep Knowledge Analytics are particularly active in the AI for Drug Discovery sector, starting with its 2014 seed investment in industry leader Insilico Medicine, whereas the Pharma Division of Deep Knowledge Analytics has become the unparalleled leader of deep quantitative analysis of the AI for Drug Discovery sector.

     Aging Analytics Agency is the Longevity-focused analytical subsidiary of Deep Knowledge Ventures, and currently serves as the Longevity, Preventive Precision Medicine and Economics of Aging data analytics source for the All-Party Parliamentary Group for Longevity.

     In addition to his business activities, Dmitry is involved in several scientific endeavours. He strongly believes that humans should live longer healthier lives. He has a major interest in Healthy Longevity which is reflected in his business, research and public activities.

​

     Dmitry’s $1 million USD prize for the first person to reach their 123th birthday went viral, and was widely covered by the world’s top media. The current lifespan record is 122.5 years, achieved by Jeanne Calment in 1997, which has remained unchanged despite the tremendous advances in biomedicine and in our understanding of the aging process that have occurred since that time. Kaminskiy chose to launchthis prize in order to promote Healthy Longevity, and to motivate people to maximize their own Healthy Longevity. Given the dynamic of progress in the field of Longevity, it is only a matter of time before this record is surpassed through the proactive efforts of someone using all available resources, both scientific, technological and lifestyle-related, to maximize their Healthy Longevity and celebrate his or her 123rd birthday.

​

     Dmitry adheres to the principal of “Impact Investing” in all his business activities, believing that business should intentionally make a significant impact for social good. He operates according to the maxim that business should be aligned with societal good and humanitarianism, and his activities in both business and the non-profit sector are aimed at the shared goal of advancing exponential and disruptive technologies to accelerate positive paradigm shifts in finance, healthcare and AI.

     Dmitry’s most prioritized current project is the launch of Longevity.Capital, a specialised investment fund focused on the longevity industry, powered by comprehensive multidimensional analytical system developed by Aging Analytics Agency to structure advanced investment strategy.